RICHEN(SH:603755) Jing Ji Guan Cha Wang·2026-02-11 05:49Core Viewpoint - The investment plan of Richen Co., Ltd. (603755.SH) in the big data company Dongfang Jinxin has encountered obstacles, leading to regulatory intervention due to several key issues [1] Financial Status - As of September 30, 2025, the company's cash balance is only 112 million yuan, while the total investment amount is 266 million yuan, approximately 2.4 times its cash on hand [2] - The company has short-term loans of 115 million yuan and long-term loans of 111 million yuan, resulting in a debt ratio of 31.85%. There are concerns that the funding for the transaction will increase financial pressure [2] Business Progress - Richen Co., Ltd. primarily engages in compound seasoning, while the target company Dongfang Jinxin is a big data software developer, indicating a significant disparity in business fields. The announcement did not clarify the synergy with the main business, technology integration path, or management experience support, defining the investment merely as a "financial investment" [3] - Regulatory authorities have requested the company to provide additional disclosures regarding the commercial logic and risk management measures [3] Recent Performance - Dongfang Jinxin reported a net profit of -97,700 yuan in 2024, but turned profitable in the first three quarters of 2025 with a profit of 1,153,670 yuan, although the scale of profitability remains small and historical performance has been volatile [4] - The investment corresponds to a valuation of approximately 2.029 billion yuan, significantly down from its post-investment valuation of 3.55 billion yuan in 2022. The agreement does not include performance commitments, leaving Richen Co., Ltd. to bear operational uncertainties [4] Policy Regulation - The Shanghai Stock Exchange issued a regulatory letter on February 7, 2026, requiring the company to explain the source of funds, the rationale for cross-industry investment, and risk response mechanisms. Recent years have seen heightened regulatory scrutiny on "blind cross-industry" and "hype-driven" behaviors, particularly focusing on aggressive investments by financially strained companies [5]